Literature DB >> 27257317

Can glycoprofiling be helpful in detecting prostate cancer?

Štefan Belický1, Jan Tkac1.   

Abstract

Glycans are chains of carbohydrates attached to proteins (glycoproteins and proteoglycans) or lipids (glycolipids). Glycosylation is a posttranslational modification and glycans have a wide range of functions in a human body including involvement in oncological diseases. Change in a glycan structure cannot only indicate presence of a pathological process, but more importantly in some cases also its stage. Thus, a glycan analysis has a potential to be an effective and reliable tool in cancer diagnostics. Lectins are proteins responsible for natural biorecognition of glycans, even carbohydrate moieties still attached to proteins or whole cells can be recognized by lectins, what makes them an ideal candidate for designing label-free biosensors for glycan analysis. In this review we would like to summarize evidence that glycoprofiling of biomarkers by lectin-based biosensors can be really helpful in detecting prostate cancer.

Entities:  

Keywords:  biomarkers; biosensors; electrochemical impedance spectroscopy; glycans; lectins; prostate cancer

Year:  2014        PMID: 27257317      PMCID: PMC4886849          DOI: 10.1515/chempap-2015-0052

Source DB:  PubMed          Journal:  Chem Zvesti        ISSN: 0366-6352            Impact factor:   2.097


  147 in total

Review 1.  Phases of biomarker development for early detection of cancer.

Authors:  M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

Review 2.  Recombinant antibodies for the generation of antibody arrays.

Authors:  Carl A K Borrebaeck; Christer Wingren
Journal:  Methods Mol Biol       Date:  2011

3.  Structure of the haptoglobin-haemoglobin complex.

Authors:  Christian Brix Folsted Andersen; Morten Torvund-Jensen; Marianne Jensby Nielsen; Cristiano Luis Pinto de Oliveira; Hans-Petter Hersleth; Niels Højmark Andersen; Jan Skov Pedersen; Gregers Rom Andersen; Søren Kragh Moestrup
Journal:  Nature       Date:  2012-08-26       Impact factor: 49.962

4.  Molecular microheterogeneity of prostate specific antigen in seminal fluid by mass spectrometry.

Authors:  Ákos Végvári; Melinda Rezeli; Carina Sihlbom; Jari Häkkinen; Elisabet Carlsohn; Johan Malm; Hans Lilja; Thomas Laurell; György Marko-Varga
Journal:  Clin Biochem       Date:  2011-12-16       Impact factor: 3.281

5.  Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA.

Authors:  Glòria Tabarés; Catherine M Radcliffe; Sílvia Barrabés; Manel Ramírez; R Núria Aleixandre; Wolfgang Hoesel; Raymond A Dwek; Pauline M Rudd; Rosa Peracaula; Rafael de Llorens
Journal:  Glycobiology       Date:  2005-09-21       Impact factor: 4.313

6.  The relative importance of anatomic and PSA factors to outcomes after radical prostatectomy for prostate cancer.

Authors:  R T Vollmer; P A Humphrey
Journal:  Am J Clin Pathol       Date:  2001-12       Impact factor: 2.493

7.  Impedance spectroscopy with field-effect transistor arrays for the analysis of anti-cancer drug action on individual cells.

Authors:  A Susloparova; D Koppenhöfer; X T Vu; M Weil; S Ingebrandt
Journal:  Biosens Bioelectron       Date:  2012-06-26       Impact factor: 10.618

8.  Peptide aptamers in label-free protein detection: 1. Characterization of the immobilized scaffold.

Authors:  Jason J Davis; Jan Tkac; Sophie Laurenson; Paul Ko Ferrigno
Journal:  Anal Chem       Date:  2007-02-01       Impact factor: 6.986

Review 9.  Emerging principles for the therapeutic exploitation of glycosylation.

Authors:  Martin Dalziel; Max Crispin; Christopher N Scanlan; Nicole Zitzmann; Raymond A Dwek
Journal:  Science       Date:  2014-01-03       Impact factor: 47.728

Review 10.  Emerging roles of human prostatic Acid phosphatase.

Authors:  Hoon Young Kong; Jonghoe Byun
Journal:  Biomol Ther (Seoul)       Date:  2013-01       Impact factor: 4.634

View more
  6 in total

1.  Label-free chronopotentiometric glycoprofiling of prostate specific antigen using sialic acid recognizing lectins.

Authors:  Stefan Belicky; Hana Černocká; Tomas Bertok; Alena Holazova; Kamila Réblová; Emil Paleček; Jan Tkac; Veronika Ostatná
Journal:  Bioelectrochemistry       Date:  2017-06-19       Impact factor: 5.373

2.  Graphene oxide-based electrochemical label-free detection of glycoproteins down to aM level using a lectin biosensor.

Authors:  L Klukova; J Filip; S Belicky; A Vikartovska; J Tkac
Journal:  Analyst       Date:  2016-06-09       Impact factor: 4.616

3.  Distinct urinary glycoprotein signatures in prostate cancer patients.

Authors:  Rebeca Kawahara; Fabio Ortega; Livia Rosa-Fernandes; Vanessa Guimarães; Daniel Quina; Willian Nahas; Veit Schwämmle; Miguel Srougi; Katia R M Leite; Morten Thaysen-Andersen; Martin R Larsen; Giuseppe Palmisano
Journal:  Oncotarget       Date:  2018-09-04

4.  Sensitive detection and glycoprofiling of a prostate specific antigen using impedimetric assays.

Authors:  D Pihíková; Š Belicky; P Kasák; T Bertok; J Tkac
Journal:  Analyst       Date:  2015-12-09       Impact factor: 4.616

5.  Mixed Zwitterion-Based Self-Assembled Monolayer Interface for Impedimetric Glycomic Analyses of Human IgG Samples in an Array Format.

Authors:  Tomas Bertok; Erika Dosekova; Stefan Belicky; Alena Holazova; Lenka Lorencova; Danica Mislovicova; Darina Paprckova; Alica Vikartovska; Robert Plicka; Jan Krejci; Marketa Ilcikova; Peter Kasak; Jan Tkac
Journal:  Langmuir       Date:  2016-07-06       Impact factor: 3.882

6.  Full-length antibodies versus single-chain antibody fragments for a selective impedimetric lectin-based glycoprofiling of prostate specific antigen.

Authors:  Stefan Belicky; Pavel Damborsky; Julia Zapatero-Rodríguez; Richard O'Kennedy; Jan Tkac
Journal:  Electrochim Acta       Date:  2017-08-20       Impact factor: 6.901

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.